Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 1,267 results.

Thumbnail for The Effect of Bezuclastinib on the Pathobiology of Mastocytosis: Changes in Bone Marrow Mast Cells, Tryptase, and KIT p.D816V Variant Allele Frequency From the Pivotal Summit Trial

MPN - 1154

The Effect of Bezuclastinib on the Pathobiology of Mastocytosis: Changes in Bone Marrow Mast Cells, Tryptase, and KIT p.D816V Variant Allele Frequency From the Pivotal Summit Trial

Dana Longo

Poster Presenter: Dana Longo

Thumbnail for The Effect of Bezuclastinib on the Pathobiology of Advanced Systemic Mastocytosis: Results from the Pivotal Apex Trial

MPN - 1161

The Effect of Bezuclastinib on the Pathobiology of Advanced Systemic Mastocytosis: Results from the Pivotal Apex Trial

Tram Le

Poster Presenter: Tram Le

Thumbnail for Efficacy and Safety of Bezuclastinib in Patients With Advanced Systemic Mastocytosis: Results From the Apex Study

MPN - 1187

Efficacy and Safety of Bezuclastinib in Patients With Advanced Systemic Mastocytosis: Results From the Apex Study

Cristina Papayannis

Poster Presenter: Cristina Papayannis

Thumbnail for RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis

MPN - 120

RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis

Naseema Gangat

Poster Presenter: Naseema Gangat

Thumbnail for Real-World Use of Pacritinib in Myelofibrosis: Results From the TriNetX Analysis on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Platelets =50Χ109/L at Initiation (TRIPAC)

MPN - 1200

Real-World Use of Pacritinib in Myelofibrosis: Results From the TriNetX Analysis on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Platelets =50Χ109/L at Initiation (TRIPAC)

Faizan Sattar

Poster Presenter: Faizan Sattar

Thumbnail for Discovery and Characterization of DMR-001, an Fc-Null, Half-Life-Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

MPN - 1206

Discovery and Characterization of DMR-001, an Fc-Null, Half-Life-Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

Mark Benton

Poster Presenter: Mark Benton

Thumbnail for Arterial and Venous Thrombosis in Myeloproliferative Neoplasm Hospitalizations: Distinct Associations With Mortality and Resource Utilization

MPN - 1235

Arterial and Venous Thrombosis in Myeloproliferative Neoplasm Hospitalizations: Distinct Associations With Mortality and Resource Utilization

Priyanka Nagdev

Poster Presenter: Priyanka Nagdev

Thumbnail for Expanded Results From the Phase 2 Summit Trial: Bezuclastinib in Adults With Nonadvanced Systemic Mastocytosis

MPN - 1268

Expanded Results From the Phase 2 Summit Trial: Bezuclastinib in Adults With Nonadvanced Systemic Mastocytosis

Pankit J Vachhani

Poster Presenter: Pankit J Vachhani

Thumbnail for KRAS Mutations in Histiocytic Neoplasms: Mutation Spectrum and Response to MEK Inhibition

MPN - 1280

KRAS Mutations in Histiocytic Neoplasms: Mutation Spectrum and Response to MEK Inhibition

Dongni Yi

Poster Presenter: Dongni Yi

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.